There is increasing evidence that many risk loci found using genome-wide association studies are molecular quantitative trait loci (QTLs). Here we introduce a new set of functional annotations based on causal posterior probabilities of fine-mapped molecular cis-QTLs, using data from the Genotype-Tissue Expression (GTEx) and BLUEPRINT consortia. We show that these annotations are more strongly enriched for heritability (5.84× for eQTLs; P = 1.19 × 10 −31 ) across 41 diseases and complex traits than annotations containing all significant molecular QTLs (1.80× for expression (e)QTLs). eQTL annotations obtained by meta-analyzing all GTEx tissues generally performed best, whereas tissue-specific eQTL annotations produced stronger enrichments for blood-and brain-related diseases and traits. eQTL annotations restricted to loss-of-function intolerant genes were even more enriched for heritability (17.06× ; P = 1.20 × 10 −35 ). All molecular QTLs except splicing QTLs remained significantly enriched in joint analysis, indicating that each of these annotations is uniquely informative for disease and complex trait architectures.
A lthough genome-wide association studies (GWAS) have been extremely successful in detecting thousands of risk loci for diseases and traits [1] [2] [3] , our understanding of disease architecture is far from complete because most risk loci lie in noncoding regions of the genome [4] [5] [6] [7] [8] [9] . Leveraging molecular phenotypes, such as gene expression [10] [11] [12] [13] [14] or chromatin marks [15] [16] [17] [18] , can help us to understand the disease architecture: in particular, previous studies have shown that cis-expression quantitative trait loci (eQTLs) are enriched in GWAS loci as well as genome-wide heritability of several diseases 5, 6, 19, 20 , motivating further work on colocalization [21] [22] [23] and transcriptome-wide association studies (TWAS) [24] [25] [26] . Partitioning heritability using raw genotypes and phenotypes [27] [28] [29] [30] [31] or summary association statistics [32] [33] [34] can aid our understanding of disease architectures, but it is currently unclear how to best leverage molecular QTLs from rich resources, such as the GTEx 12, 14 and BLUEPRINT 18 consortia, using these methods.
Here we introduce a set of annotations constructed from eQTL, histone (h)QTL, splicing (s)QTL and methylation (me)QTL data that are very strongly enriched for disease heritability across 41 independent diseases and complex traits. We construct these annotations by applying a fine-mapping method 35 (allowing for multiple causal variants at a locus) to compute causal posterior probabilities for each variant to be a causal cis-QTLs. We show that our annotations are far more enriched for disease heritability than standard annotations. We further show that our eQTL annotations produce tissue-specific enrichments (despite high cis-genetic correlations of eQTL effect sizes across tissues 12, 36 , and produce much larger enrichments when restricted to loss-of-function intolerant genes from Exome Aggregation Consortium (ExAC) 37 data. Finally, we quantify the extent to which annotations constructed from eQTL, hQTL, sQTL and meQTL data provide complementary information about disease.
Results
Overview of methods. Our goal is to construct molecular QTLbased annotations that are maximally enriched for disease heritability. For a given molecular QTL dataset, we construct a probabilistic (continuous-valued) annotation as follows. First, for each molecular phenotype (for example, each gene) with at least one significant (false discovery rate (FDR) < 5%) cis-QTLs (1 Mb from transcription start site (TSS)), we compute the causal posterior probability (CPP) of each cis-SNP in the fine-mapped 95% credible set, using our CAusal Variants Identification in Associated Regions (CAVIAR) fine-mapping method 35 (see URLs) . Then, for each SNP in the genome, we assign an annotation value based on the maximum value of CPP across all molecular phenotypes; SNPs that do not belong to any 95%CredibleSet are assigned an annotation value of 0. We refer to this annotation as MaxCPP. For comparison purposes, we also construct three other molecular QTL-based annotations. First, we construct a binary annotation containing all SNPs that are a significant (FDR < 5%) cis-QTLs for at least one molecular phenotype 19, 20 ; we refer to this annotation as Allcis-QTLs. Second, we construct a binary annotation containing all SNPs that belong to the 95% credible set (see above) for at least one molecular phenotype; we refer to these data as the 95% credible set. Third, we construct a binary annotation containing the most significant SNP for each molecular Leveraging molecular quantitative trait loci to understand the genetic architecture of diseases and complex traits phenotype with at least one significant (FDR < 5%) QTL. We refer to this annotation as Topcis-QTL (see Methods).
We applied a previously developed method, stratified linkage disequilibrium (LD) score regression (S-LDSC) 32, 33 , to these data, to partition disease heritability using functional annotations. We used two metrics to quantify the contribution of an annotation to disease heritability: enrichment and standardized effect size (τ * ). Enrichment is defined as the proportion of heritability explained by SNPs in an annotation divided by the proportion of SNPs in the annotation 32 ; here, we generalize this definition to probabilistic annotations such as MaxCPP. Standardized effect size (τ * ) is defined as the proportionate change in per-SNP heritability associated with an increase in the value of the annotation by one standard deviation, conditional on other annotations included in the model 33 . Unlike enrichment, τ * quantifies effects that are unique to the focal annotation (see Methods).
We constructed MaxCPP and other annotations using eQTL data from the GTEx Consortium 12, 14 and eQTL, hQTL, sQTL and meQTL data from the BLUEPRINT Consortium 18 (Table 1 ; see URLs). We included a broad set of 75 functional annotations from the baselineLD model ( Supplementary Table 1 ) in most analyses. We have made our annotations and partitioned LD scores freely available (see URLs).
Simulations.
We performed a comprehensive set of simulations to assess whether S-LDSC produces unbiased estimates of the contribution of an annotation to disease heritability for the Allcis-QTLs, 95%CredibleSet, Topcis-QTL and MaxCPP annotations. We performed simulations using real genotypes from the UK Biobank, restricting to 749,024 SNPs on chromosome 1 (see Methods). In our main simulation, we simulated gene expression phenotypes for 500 individuals assuming that 10% of cis variants for a gene are causal cis-eQTLs (heritability = 16%), simulated complex trait phenotypes for an independent set of 40,000 individuals assuming that the set of causal variants is exactly the set of causal eQTLs, with independent effect sizes (heritability = 20%), and subsequently assumed that 10% of causal eQTLs are missing from the data analyzed. We also performed secondary simulations under other genetic architectures and assumptions about missing data (see below). We estimated the contribution of each annotation to complex trait heritability using S-LDSC. We performed 400 independent simulations, and averaged results across simulations.
Enrichment estimates and true enrichments for each annotation are shown in Fig. 1 and Supplementary Table 2 . We determined that S-LDSC estimates are severely upward biased for the Topcis-QTL annotation. On the other hand, S-LDSC estimates were slightly conservative for the Allcis-QTL, 95% credible set and MaxCPP annotations. Thus, we restrict our analyses to these three annotations in our analyses of real phenotypes below. Of these three annotations, MaxCPP had the highest enrichment ( Fig. 1 and Supplementary   Table 2 ). For comparitive purposes, we also computed estimates using genome-wide complex trait analysis (GCTA) 27, 28 (see URLs), a method that has previously been applied to assess eQTL enrichment for complex traits 19, 20 ; we computed GCTA estimates for all annotations except MaxCPP, as GCTA is only applicable to binary annotations. We determined that GCTA estimates generally exhibited greater bias than S-LDSC estimates ( Fig. 1 and Supplementary  Tables 2, 3 ). We obtained similar results for both S-LDSC and GCTA using other simulation parameters ( Supplementary Table 3 ). We also obtained similar results for both S-LDSC and GCTA using an alternative simulation framework, drawn from our previous work 25 . This framework directly uses simulated gene expression to generate complex trait phenotypes (see Methods and Supplementary Table 4 ).
All functional enrichment methods (GCTA 27,28 , BOLT-REML 30 , S-LDSC 32, 33 , and Linkage-Disequilibrium Adjusted Kinships (LDAK) 31 ) that we are currently aware of assume that causal disease effect sizes are independent and identically distributed conditional on minor allele frequency (MAF), LD and function annotation values. However, this assumption may be violated for molecular QTLbased annotations when causal variants are sparse (see Methods for an example); in particular, this is a limitation of our S-LDSC method. Indeed, our simulations confirm these biases ( Fig. 1 and Supplementary Tables 2-4 ). We note that other functional enrichment methods are also subject to this limitation. Specifically, GCTA 27,28 is shown by our simulations to exhibit greater biases than S-LDSC ( Fig. 1 and Supplementary Tables 2-4 ). BOLT-REML 30 is a computationally efficient method that produces the same results as GCTA 27, 28 . For analysis of LDAK 31 , please see previous work 38 . S-LDSC produces slightly conservative estimates across a comprehensive set of simulations for the Allcis-QTL, 95%CredibleSet and MaxCPP annotations that we consider in our analyses of real phenotypes below.
Fine-mapped eQTLs are enriched for disease heritability. We used the GTEx eQTL dataset (Table 1) to construct the Allcis-QTL, 95% credible set and MaxCPP annotations. We constructed annotations using each of the 44 tissues (Supplementary Table 5 ). We applied S-LDSC to assess the contribution of each annotation to disease heritability for each of the 41 independent diseases and complex trait datasets (average N = 320,000); for six traits we analyzed two different datasets, leading to a total of 47 datasets analyzed (Supplementary Table 6 ). We meta-analyzed results across the 47 datasets, which were chosen to be independent (see Methods). We computed enrichment and τ * for each annotation, in analyses that included 75 functional annotations ( Supplementary Table 1 ) from the baselineLD model 33 . Results for whole blood, a widely studied tissue, are reported in Fig. 2 and Supplementary Table 7 . We determined that the MaxCPP annotation had far higher values of enrichment and τ * than Allcis-QTLs or 95%CredibleSet; the enrichment estimates remain much higher for MaxCPP even after accounting for the fact that S-LDSC generally produces more conservative estimates for Allcis-QTLs and 95% credible set than for MaxCPP in our simulations (1.10-1.58× and 0.76-1.23× more conservative, respectively, across all simulations; Fig. 2 and Supplementary Table 7 ). The MaxCPP annotation also had higher values of enrichment and τ * in analyses that did not condition on the baselineLD model (Supplementary Fig. 1 and Supplementary Table 8 ).
We investigated whether the τ * for MaxCPP in each respective tissue varied with sample size. We observed a correlation (R 2 = 0.69, P = 1.36 × 10 −12 ) between sample size and τ * ( Fig. 3 and Supplementary Table 9 ). We observed a similar pattern in simulations ( Supplementary Fig. 2 ). This suggests that the correlation between sample size and τ * in GTEx data is related to statistical power and not because tissue-specific eQTL from tissues with larger sample size are more relevant for the 41 traits that we analyzed. Thus, annotations constructed from tissues with larger sample sizes are more informative for disease and trait architectures.
To maximize sample size, we performed a fixed-effect metaanalysis of eQTL effect sizes across the 44 tissues (FE-Meta-Tissue; see Methods). We determined that FE-Meta-Tissue annotations had slightly larger enrichments and much larger τ * (due to larger annotation size) than annotations constructed from individual tissues ( Fig. 2 and Supplementary Tables 7, 10). As with individual tissues, the MaxCPP annotation had far higher values of enrichment (5.84× , s.e. = 0.40; P = 1.19 × 10 −31 ) and τ * (τ * = 0.52, s.e. = 0.05; P = 2.73 × 10 −27 ) than Allcis-QTL (enrichment = 1.80× and τ * = 0.03) or 95%CredibleSet (enrichment = 2.75× and τ * = 0.17) annotations. Of particular note, the τ * for GTEx FE-Meta-Tissue MaxCPP (conditional on the baselineLD model) is much larger than the τ * values of the six continuous annotations that we introduced in our previous work 33 (Supplementary Table 11 ). A histogram of MaxCPP annotation values for GTEx FE-Meta-Tissue is provided in Supplementary Fig. 3 , and correlations with baselineLD model annotations and their LD scores are provided in Supplementary Figs. 4, 5.
Tissue-specific fine-mapped eQTLs enriched for heritability.
Although the FE-eMta-Tissue MaxCPP annotation outperformed each of the 44 tissue-specific MaxCPP annotations in the metaanalysis across 41 traits (Figs. 2, 3), this was not the case for every trait. We examined six autoimmune diseases, five blood cell traits, and eight brain-related diseases and traits in detail (see Methods). We first analyzed the six autoimmune diseases, analyzing MaxCPP annotations for blood and FE-Meta-Tissue separately (conditional on the baselineLD model) and meta-analyzing results across the six diseases. We obtained higher estimates of τ * (and higher or comparable estimates of enrichment) for blood than for FE-Meta-Tissue or any other individual tissue ( Supplementary Table 12 ). We then analyzed MaxCPP annotations for blood and FE-meta-tissue jointly (conditional on the baselineLD model). We obtained a significantly positive τ * estimate for blood (τ * = 0.91, s.e. = 0.34; P = 9.15 × 10 −3 ; Fig. 4 and Supplementary Table 13 ), indicating that fine-mapped blood eQTLs provides additional information about these six diseases conditional on fine-mapped FE-Meta-Tissue eQTLs. We repeated these analyses for the five blood cell traits. When analyzing MaxCPP annotations for blood and FE-Meta-Tissue separately, we obtained higher estimates of τ * (and higher or comparable estimates of enrichment) for blood than for FE-meta-tissue or any other individual tissue ( Supplementary Table 14 ). When analyzing MaxCPP annotations for blood and FE-Meta-Tissue jointly, we obtained a significantly positive τ * estimate for blood (τ * = 1.17, s.e. = 0.24; P = 1.77 × 10 −6 ; Fig. 4 and Supplementary Table 13 ), indicating that fine-mapped blood eQTLs provide additional information about these five traits conditional on fine-mapped FE-meta-tissue eQTLs. The correlations of blood MaxCPP annotation values with baselineLD model annotations and their LD scores are provided in Supplementary Figs. 6, 7.
We then analyzed the eight brain-related diseases and traits. We performed a fixed-effect meta-analysis of eQTL effect sizes across the 10 brain tissues and one nerve tissue (brain and nerve). When analyzing MaxCPP annotations for brain and nerve tissues and FE-Meta-Tissue separately, we obtained higher or comparable estimates of enrichment and τ * for brain and nerve tissues than for FE-meta-tissue or any individual tissue ( Supplementary Table 15 ). When analyzing MaxCPP annotations for brain and nerve tissues and FE-Meta-Tissue jointly, we obtained a significantly positive τ * estimate for brain and nerve tissues (τ * = 0.28, s.e. = 0.07; P = 9.81 × 10 −5 ) ( Fig. 4 and Supplementary Table 13 ), indicating that fine-mapped eQTLs for brain and nerve tissues provide additional information about these eight traits conditional on fine-mapped FE-Meta-Tissue eQTLs. The correlations between the MaxCPP annotation values of brain and nerve tissues and the baselineLD model annotations and their LD scores are provided in Supplementary Figs. 6, 7. We repeated these analyses for each trait and each tissue separately, but determined that only three blood cell traits (white blood count, red blood cell distribution width and eosinophil count traits), in conjunction with MaxCPP for blood, attained a significantly positive (FDR < 5%) tissue-specific τ * (Supplementary Tables 16, 17 ). Overall, these results demonstrate that tissue-specific eQTL effects on steady-state expression can be significant for diseases and complex traits, despite the well-documented high cis-genetic correlations of eQTL effect sizes across tissues 12, 36 .
MaxCPP signal is concentrated in disease-relevant gene sets.
Recent studies have identified gene sets that are depleted for Supplementary Table 7 .
coding variants and enriched for de novo coding mutations that affect disease 37, 39, 40 . To investigate the importance of non-coding common variants in these gene sets, for each gene set S we used GTEx FE-Meta-Tissue to construct a new annotation MaxCPP(S), defined as the maximum CPP restricted to genes in S. For comparison purposes, we also constructed an annotation allSNP(S), defined as the set of all SNPs within 100 kb of genes in S. We first analyzed the ExAC gene set, which consists of 3,230 genes that are strongly depleted of protein-truncating variants 37 . We determined that MaxCPP(ExAC) was very strongly enriched in an analysis conditional on the baselineLD model, meta-analyzed across 41 independent traits (see Fig. 5a and Supplementary Table 18 ). In particular, MaxCPP(ExAC) was much more strongly enriched (17.06× , s.e. = 1.28; P = 1.20 × 10 −35 ) than MaxCPP(all genes) (5.84× ; P = 4.90 × 10 −17 for difference). This indicates that eQTLs for these 3,230 genes have a disproportionately strong effect on disease heritability, consistent with the fact that these genes are depleted of eQTLs 37 . We then analyzed MaxCPP(ExAC) and maxCPP(all genes) annotations jointly (conditional on the baselineLD model). We obtained a significantly positive τ * for MaxCPP(ExAC) (τ * = 0.41, s.e. = 0.04; P = 1.40 × 10 −23 ; Fig. 5b and Supplementary Table 19 ), indicating that MaxCPP(ExAC) provides additional information about disease heritability conditional on maxCPP(all genes). We observed that the effect size (τ * ) for MaxCPP(ExAC) conditional on MaxCPP(all genes) and baselineLD is five times larger, and more statistically significant, than the τ * of allSNP(ExAC) conditional on the baselineLD model ( Supplementary Table 20 ). Thus, MaxCPP can increase the power to identify enriched gene sets.
We analyzed four additional gene sets S: a set of 1,003 genes that are strongly depleted of missense mutations 40 (Samocha) ; a set of 2,984 genes with strong selection against protein-truncating variants 39 (Cassa) ; a set of 1,878 genes predicted to be essential based on CRISPR experiments in a human cancer cell line 41 (Wang) ; and a set Supplementary Table 10 . For visualization purposes, we use the following abbreviations: adipose visceral, adipose visceral omentum; brain ACC, brain anterior cingulate cortex BA24; brain CBG, brain caudate basal ganglia; brain CH, brain cerebellar hemisphere; brain FC, brain frontal cortex BA9; brain NABG, brain nucleus accumbens basal ganglia; brain PBG brain putamen basal ganglia; cells CETL, cells EBV-transformed lymphocytes; cells TF, cells transformed fibroblasts; esophagus-GJ, esophagus gastroesophageal junction; heart AA, heart atrial appendage; heart LV, heart left ventricle; skin NSES, skin not sun exposed suprapubic; skin SELL, skin sun exposed lower leg; small intestine, small intestine terminal ileum. Supplementary Table 13. of 11,983 genes with evidence of allelic heterogeneity in analyses of GTEx gene expression data using our previously developed methods (AH) 42 . For each of these gene sets, MaxCPP(S) was strongly enriched in analyses conditional on the baselineLD model, metaanalyzed across 41 independent traits ( Fig. 5a and Supplementary  Table 18 ). In addition, for each gene set except the Wang gene set, we obtained a significantly positive τ * for MaxCPP(S) (after correcting for five gene sets tested) when analyzing MaxCPP(S) and MaxCPP(all genes) jointly (conditional on the baselineLD model) ( Fig. 5b , Supplementary Tables 19, 21 -25) . As with the ExAC gene set, the τ * for MaxCPP(S) conditional on MaxCPP(all genes) and the baselineLD model were substantially larger than the τ * of allSNPs(ExAC) conditional on the baselineLD model and were often more statistically significant ( Supplementary Table 20 ), indicating that MaxCPP can increase the power to identify enriched gene sets in which regulatory variants have an important role.
Fine-mapped molecular QTLs are enriched for heritability. We analyzed five molecular QTLs from the BLUEPRINT dataset (Table  1) , including eQTLs, hQTLs (H3K27ac and H3K4me1), sQTLs and meQTLs. In each case, we constructed the Allcis-QTL, 95% credible set and MaxCPP annotations using each of the three immune cell types (CD14 + monocytes, CD16 + neutrophils, and naive CD4 + T cells; Supplementary Table 26 ) as well as a fixed-effect meta-analysis of molecular QTL effect sizes across the three cell types (FE-Meta-Tissue). We determined that for each QTL dataset the MaxCPP annotation outperformed the Allcis-QTL and 95% credible set annotations ( Supplementary Table 27 ). A histogram of MaxCPP annotation values for each QTL dataset is provided in Supplementary Fig. 8 . MaxCPP for each molecular QTL was significantly enriched in an analysis conditional on the baselineLD model, meta-analyzed across the 41 traits: eQTLs ( Fig. 6a and Supplementary Table 28 ); the enrichment for BLUEPRINT eQTLs was almost as large as the enrichment for GTEx eQTLs (5.84× ), despite the much smaller total sample size of FE-Meta-Tissue in BLUEPRINT. This indicates that BLUEPRINT sample sizes, though small, are adequately powered for eQTL detection. Consistent with this finding, we observed a high replication rate between cis-QTLs in GTEx and BLUEPRINT (see Supplementary  Table 29 ), confirming that GTEx FE-Meta-Tissue analyses provide increased power relative to GTEx blood ( Supplementary Table 28 ). BLUEPRINT FE-meta-tissue generally attained higher enrichment and τ * values than MaxCPP computed using each of the three immune cell types individually ( Supplementary Table 30 ), similar to our GTEx results ( Supplementary Tables 7, 10 ). MaxCPP computed using FE-Meta-Tissue also generally outperformed each of the three cell types in a meta-analysis across the six autoimmune diseases ( Supplementary Table 31 ) and a meta-analysis across the five blood cell traits ( Supplementary Table 32 ), in contrast to the stronger enrichments for tissue-specific GTEx blood eQTL annotations for blood cell traits ( Supplementary Tables 12, 14 ). FE-Meta-Tissue generally attained higher enrichments and τ * than MaxCPP computed using each of the three immune cell types individually ( Supplementary  Table 30 ), similar to our GTEx results ( Supplementary Tables 7, 10 ).
MaxCPP computed using FE-Meta-Tissue also generally outperformed each of the three cell types in a meta-analysis across the six autoimmune diseases ( Supplementary Table 31 ) and a meta-analysis across the five blood cell traits ( Supplementary Table 32 ), in contrast to tissue-specific results in GTEx (Supplementary Tables 12, 14 ). Finally, we jointly analyzed MaxCPP annotations for GTEx eQTLs and each of the five BLUEPRINT molecular QTLs (conditional on the baselineLD model). The purpose of this analysis was to determine whether each of these molecular QTLs provided independent information about disease and complex trait architectures. We determined that τ * remained statistically significant for all molecular QTLs except sQTLs ( Fig. 6b and Supplementary Table  33 ); a joint analysis of just the five BLUEPRINT molecular QTLs (conditional on the baselineLD model) produced similar findings ( Supplementary Table 34 ). LD scores of the sQTL annotation had the highest correlation with LD scores of the GTEx eQTL and BLUEPRINT eQTL annotations (R = 0.56-0.57; see Supplementary  Fig. 5 ), indicating that much of the informativeness of sQTLs in this analysis is captured by the eQTLs. However, eQTLs, hQTLs (H3K27ac and H3K4me1) and meQTLs are each uniquely informative for disease and complex trait architectures.
Discussion
We have shown that annotations constructed using fine-mapped posterior probabilities for several different molecular QTLs are strongly enriched for disease heritability. These results improve upon two previous studies that made key contributions in showing that annotations constructed using all significant cis-eQTLs were significantly enriched for trait heritability 19, 20 . Our findings provide additional motivation for colocalization studies [21] [22] [23] and TWAS [24] [25] [26] . Our fine-mapped eQTL annotations were able to detect tissuespecific enrichments for blood-and brain-related traits, despite high cis-genetic correlations 12, 36 of eQTL effect sizes across tissues and despite the fact that TWAS have generally concluded that their results 'did not suggest tissue-specific enrichment' 26 .
We note that a previous study showed that cis-eQTLs often lie close to the TSS or transcription end site (TES) 43 , motivating us to investigate the orthogonal question of whether cis-eQTLs that lie near the TSS or TES produce more disease signal than cis-eQTLs that do not lie near the TSS or TES; we did not observe such an effect in the GTEx or BLUEPRINT datasets (see Supplementary  Tables 35, 36 ). Notably, our eQTL annotations produced particularly large enrichments when restricted to disease-relevant gene sets, such as loss-of-function intolerant genes from ExAC, highlighting the potential to increase signal in analyses of gene sets that contain regulatory signals by prioritizing fine-mapped cis-eQTLs. Our eQTL annotations may also prove useful in future analyses of gene pathways. Supplementary Table 18 .
We also detected strong enrichments using annotations based on other molecular QTLs, with eQTLs, hQTLs and meQTLs all providing complementary information about disease, conditional on each other and on functional annotations from previous studies. These results motivate applying colocalization and TWAS methods to other molecular QTLs; it may also be possible to prioritize other molecular QTLs in gene set analyses by connecting regulatory regions to genes 44, 45 . Although annotations constructed from sQTLs were not conditionally significant in our analysis, previous work has shown that sQTLs can contain information that is independent from eQTLs 46 , motivating further investigation in larger sQTL datasets.
We note several limitations of our work. First, we restrict our analyses to common variants, as S-LDSC is not currently applicable to rare variants 47 . Recent work has shown that rare variants can have substantial effects on gene expression 50 , motivating ongoing work to extending S-LDSC to rare variants. Second, the CAVIAR finemapping method allows up to six causal variants per locus; this may limit power at loci that have more than six causal variants, although this would not lead to spurious signals. We determined that our results were very similar when modifying CAVIAR to allow up to three causal variants per locus ( Supplementary Figs. 9, 10 and Supplementary Table 37 ), suggesting that modeling only six causal variants per locus is unlikely to greatly impact our results. Third, we show that S-LDSC is generally unable to produce unbiased enrichment estimates for molecular QTL-based annotations when causal variants are sparse, due to violations of model assumptions (which also affect other functional enrichment methods, including GCTA 27,28 , BOLT-REML 30 and LDAK 31 , which also assume that causal disease effect sizes are independent and identically distributed conditional on MAF, LD and functional annotation values); S-LDSC produces slightly conservative enrichment estimates for the MaxCPP annotation that we focus on here; however, the S-LDSC estimates should not be viewed as rigorous lower bounds, because our simulations do not include all possible genetic architectures. We caution that the Topcis-QTL annotation produces large upward biases and should be avoided (Fig. 1) . Fourth, our results are a function of the molecular QTL sample size ( Fig. 3 ) and set of tissues; although current molecular QTL sample sizes are clearly informative, analyses of larger sample sizes and/or different tissues or contexts may produce larger enrichments in the future. Fifth, we performed a fixed-effect meta-analysis of molecular QTL effect sizes across tissues (FE-Meta-Tissue) that does not account for overlapping samples and heterogeneity across tissues in eQTL effect sizes, which could in principle limit our power 48 . However, noise is largely uncorrelated across tissues (despite pervasive sample overlap), and recently developed random-effect cross-tissue eQTL meta-analysis methods 48, 49 are not applicable in the current setting (see Methods). Sixth, our approach cannot distinguish causal mediation from horizontal pleiotropy (that is, independent effects on molecular QTLs and disease), thus our molecular QTL enrichment results should not be viewed as a quantification of mediated effects. Despite these limitations, our results indicate that fine-mapped QTL annotations are strongly enriched for disease heritability and can help to elucidate the genetic architecture of diseases and complex traits.
URLs.
CAVIAR 
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41588-018-0148-2. 
Molecular QTL-based annotations. We construct four annotations for any given QTL dataset using the observed marginal association statistics. The four annotations are MaxCPP, Allcis-QTL, 95% credible set and Topcis-QTL. Each annotation is a vector that assigns a value to each SNP. Let a indicate our annotation for one QTL dataset where a j indicates the value assigned to SNP j. For binary annotations (Allcis-QTL, 95% credible set and Topcis-QTL) a j ∈ {0, 1}, and a j = 0 indicates that SNP j is not included in the annotation, whereas a j = 1 indicates that SNP j is included in the annotation. For continuous probabilistic annotations (MaxCPP), 0 ≤ a j ≤ 1. Let S = (s 1 , s 2 , … s g ) indicate an m × g matrix of the observed marginal association statistics obtained for each QTL dataset, where m is the number of SNPs and g is the number of eGenes (for example, genes that have at least one significant cis-eQTLs). Let s i be the vector of marginal association statistics of gene i for all cis variants. Utilizing s i and the LD structure, we can compute the CPP for each variant. CPP is the probability that a variant is causal. Let α ji be the posterior probability that SNP j is causal for gene i. We obtained the CPP values from CAVIAR 35 . In addition to the CPP values, CAVIAR provides a 95% credible set that contains all of the causal variants with a probability of at least 95%. Let θ ji indicate whether SNP j is in the 95% credible set for gene i (that is, θ ji = 1 indicates that SNP j is in the 95% credible set of gene i and θ ji = 0 otherwise). We constructed the MaxCPP annotation for SNP j by computing the maximum value of CPP over all genes for which SNP j is in the 95% credible set of gene i. More formally, we have: a j = max i α ji where the maximum is over genes i with θ ji = 1.
The Allcis-QTL annotation is a binary annotation, for which any variant with a marginal association statistic for at least one gene that passes the significance threshold (FDR < 0.05) has an annotation value of 1, and all other variants have an annotation value of 0. Let t ji indicate whether SNP j is statistically significant for gene i (t ji = 1 when FDR(j) < 0.05 and t ji = 0 otherwise). More formally, we have: a j = max i t ji .
The 95% credible set is a binary annotation, any variant that is in a 95% credible set of at least one gene has an annotation value of 1 and all other variants have an annotation value of 0. More formally, we have: a j = max i θ ji .
Topcis-QTL is a binary annotation where any variant that is the most significant variant for at least one gene has an annotation value of 1 and all other variants have an annotation value of 0. Let γ ji indicate whether SNP j is the most significant SNP for gene i (that is, γ ji = 1 if SNP j is the most significant SNP among all cis variants for gene i and γ ji = 0 otherwise). More formally, we have: a j = max i γ ji .
Enrichment and effect size (τ * ) metrics. We used two metrics to measure the importance of an annotation in the context of diseases and complex traits: the enrichment and standardized effect size (τ * ) of the annotation. We used S-LDSC 32, 33 to compute enrichment and standardized effect size (τ * ). Let a cj indicate the annotation value of SNP j for the annotation c. S-LDSC 32, 33 assumes that the variance of each SNP is a linear additive contribution to each annotation:
where τ c is the contribution of annotation c to per-SNP heritability. S-LDSC 32, 33 estimates τ c using the following equation:
where N is the GWAS sample size and l(j,c) is the LD score of SNP j for the annotation c. S-LDSC computes the LD scores as follow: = ∑ l j c a r ( , ) k ck jk 2 where r jk is the genetic correlation between SNPs j and k.
Because τ c depends on trait heritability and the size of the annotation, τ* c was previously defined 33 for an annotation as the standardized annotation effect size: The enrichment of an annotation is defined as the fraction of heritability captured by the annotation divided by the fraction of SNPs in that annotation. We extend the definition of enrichment to continuous probabilistic annotations with values between 0 and 1: where h c ( ) g 2 is the heritability captured by the cth annotation. We can compute this quantity as follows: Although both enrichment and τ * are computed using a model that includes all annotations, τ * quantifies effects that are unique to the focal annotation (after conditioning on all other annotations in the model), whereas enrichment quantifies effects that are unique and/or non-unique to the focal annotation. For example, consider a model that includes two annotations, in which the first annotation is a highly disease-informative functional annotation and the second annotation is the first annotation plus a random set of SNPs. Only the first annotation will have a significant τ * , but both annotations will be significantly enriched. We confirmed via simulation that, under a generative model in which only the baselineLD and GTEx FE-Meta-Tissue MaxCPP annotations directly influence trait heritability,τ * estimates for the GTEx whole-blood MaxCPP annotations are equal to 0 on average, with a correctly calibrated null distribution of P values for nonzero τ * ( Supplementary Fig. 11 ).
We computed the statistical significance level (P value) of enrichment for each annotation via block-jackknife, as described in our previous studies 32, 33, 50 . We computed the statistical significance (P value) 33 Simulation framework. Main simulation framework. We simulated both gene expression and trait phenotypes. We utilized UK Biobank genotypes from chromosome 1, which consists of 749,024 variants, for our simulation. We used 40,000 individuals to generate the trait phenotypes and a non-overlapping set of 500 individuals to generate gene expression phenotypes. Let σ ge 2 and σ t 2 indicate the total heritability of gene expression and trait phenotypes, respectively. We simulated causal trait effect sizes using a polygenetic model, β~σ
, where β i is the causal (true) effect size of the ith causal variant and n t is the number of causal variants for the trait. Similarly, we simulated causal gene expression effect sizes using a polygenetic model, β′~σ 
, where β′ ji is the causal (true) effect size of the ith causal variant on gene expression of gene j and n ge is the number of causal variants. We use the following model to simulate the gene expression and traits:
where e is the environmental and measurement noise, y is the simulated trait phenotypes, g j is the gene expression of gene j, and e j is the environmental and measurement noise for gene j. In the case of gene expression, we simulated 1,860 phenotypes to represent our simulated gene expression data as 1,860 genes lies on chromosome 1. We simulated three different datasets for which n ge is set to 1 causal variant, 10 causal variants, or 10% of cis variants that are causal for each gene. The default value of n ge is set to 10% of cis variants. In the case of trait phenotypes, we set n t to be the union of causal variants for all genes on chromosome 1
where C ge (i) is the set of causal variants for gene i). In our simulated datasets, we set σ t 2 to 0.2 and considered different values of σ ge 2 to test our results on different input parameters. We set σ ge 2 to 0.1, 0.16 and 0.2, which resulted in different simulated datasets. The default value of 0.16 is used for σ ge 2 . For each simulated dataset, we performed 400 simulations.
After simulating the gene expression and trait phenotypes, we obtained marginal association statistics for each variant using linear regression implemented in the PLINK software 51 (see URLs). In the case of simulated trait phenotypes, we computed the association of each variant with the simulated trait phenotypes (y ≈ x i ). In the case of simulated gene expression phenotypes, we computed the marginal statistics for all variants within 1 Mb of the TSS ~′ g x ( ) j i . In some simulations, we assumed that a subset of the causal variants are missing (not measured). Let n m indicate the fraction of causal eQTLs that are missing. In our simulated datasets, we set n m to 0% (no causal eQTL missing), 5% (5% of causal eQTLs are missing), 10% (10% of causal eQTLs are missing) or 50% (half of the causal eQTLs are missing). The default value of 10% is used for n m .
Alternative simulation framework. We also considered an alternative simulation framework, drawn from our previous work 25 that directly uses simulated gene expression to generate complex trait phenotypes. We utilized UK Biobank genotypes from chromosome 1, which consists of 749,024 variants, for our simulation. We used 40,000 individuals to generate the trait phenotypes and geneexpression phenotypes. We assume that the trait phenotype is a mixture of direct genotype effects (effects not mediated by gene expression) and gene-expression effects. Let After simulating the gene expression and trait phenotypes, we obtained marginal association statistics for each variant using linear regression implemented in the PLINK software 52 (see URLs). In the case of simulated trait phenotypes, we computed the association of each variant with the simulated trait phenotypes (y ~x i ). In the case of simulated gene expression phenotypes, we computed the marginal statistics for all variants within 1 Mb of the TSS ~′′ g x ( ) j i where xʺ is the subset of the X genotype matrix restricted to 500 individuals. We assumed that 10% of the causal variants are missing (not measured), that is, we set n m to 10%.
We generated the four annotations as described above. We used CAVIAR 35 to generate the 95% credible set and MaxCPP annotations. We utilized European samples from the 1000 Genomes Project (1000G) 52 (see URLs) to estimate the LD structure required as input into CAVIAR. We applied CAVIAR using setting in which we allowed up to six causal variants for each gene. We observed that the results for cases for which we allowed up to six or three causal variants for each gene are not statistically different ( Supplementary Figs. 9, 10 and Supplementary  Table 37 ). We note that the 95% credible set is not guaranteed to be unique; in this study, we used a single 95% credible set for each gene for three reasons. First, use of a single 95% credible set is consistent with the output of all existing fine-mapping methods of which we are currently aware. Second, computing all 95% credible sets for each gene is computationally costly. Third, taking the union of all 95% credible sets might reduce the enrichment and τ * , whereas the goal of this paper is to construct annotations with highest possible enrichment and τ * .
After obtaining the four annotations, we ran S-LDSC 32 to generate the LD score of each variant in each annotation using the same procedure described in the previous studies 32, 33 . Regression SNPs, which are used by S-LDSC to estimate τ from marginal association statistics, were obtained from the HapMap Project phase 3 53 . These SNPs are considered to be well-imputed SNPs. SNPs with marginal association statistics larger than 80 or larger than 0.001 N and SNPs that are in the major histocompatibility complex region were excluding from all analyses. Reference SNPs, which are used to compute LD scores, were defined using the European samples in 1000G 52 . Heritability SNPs, which are used to estimate s.d.(c) and h g 2 , were defined as common variants (MAF ≥ 0.05) in the set of reference SNPs. Using the LD score for each annotation and the marginal statistics obtained from the trait phenotypes, we computed the enrichment and τ * for each simulation. Then, we compared the S-LDSC estimated enrichment and true enrichment for each annotation. All results are averaged across 400 simulations.
In addition to S-LDSC, we used GCTA 27, 28 to compute the enrichment of each binary annotation. We first computed the GRM for each annotation using the set of all variants in that annotation. We then used the -reml option in GCTA to estimate the heritability explained by each annotation.
Concrete example for S-LDSC bias estimates of Topcis-QTL.
Let x be a SNP in the Topcis-QTL annotation, let y be a SNP not in the Topcis-QTL annotation that is in LD with x, and let z be a random SNP not in the Topcis-QTL annotation. Then the expectation is y has a larger causal disease effect size than z (violating S-LDSC model assumptions), because it is possible that y is a causal molecular QTLs (tagged by x, which may be more significant because of statistical chance), and that y is also causal for disease. The fact that SNPs in LD with the Topcis-QTL annotation have larger causal disease effect sizes may cause Topcis-QTL enrichment to be overestimated by S-LDSC, which attributes higher χ 2 statistics for such SNPs entirely to tagging of causal Topcis-QTL enrichment. On the other hand, enrichments of more inclusive annotations may be underestimated by S-LDSC, because SNPs in the annotation with high LD to other SNPs in the annotation are expected to have lower causal disease effect sizes than random SNPs in the annotation (again violating S-LDSC model assumptions).
Set of 41 independent diseases and complex traits.
We initially considered 34 GWAS summary association statistic datasets that are publicly available and 55 UK Biobank traits (see URLs) for which summary association statistics were computed using BOLT-LMM 30, 54 (see URLs; up to n = 459,000 European-ancestry samples). We restricted our analyses to 47 datasets with z-scores of total SNP heritability of at least 6 (Supplementary Table 6 ). The 47 datasets included six traits that were duplicated in two different datasets (genetic correlation of at least 0.9). Thus, we analyzed 41 independent diseases and complex traits. We ran S-LDSC using the same procedures described in previous studies 32, 33 (see above). All analyses that included the baselineLD model are based on baselineLD model v.1.1, which is identical to the baselineLD model as previously described 33 , except that we fixed an error in the promoter annotation (inherited from previous studies 32, 33 ); we determined that fixing this error did not affect our results (see Supplementary  Table 38 ). The z-score of total SNP heritability was computed using S-LDSC with the baselineLD model and the genetic correlation between pairs of traits was computed using cross-trait LDSC 55 . The meta-analyzed values of enrichment and τ * across the 47 datasets were computed using a random-effect meta-analysis, as implemented in the rmeta R package.
Fixed-effect meta-analysis of eQTL effect sizes (FE-Meta-Tissue). Given a set of effect sizes for SNP i (β 1 , β 2 , … β t ) for t tissues, where β j is the eQTL effect size for tissue j, we used fixed-effect meta-analysis (FE-Meta-Tissue) to compute inversevariance weighted meta-analysis z-scores z FE as follows: is the standard error of β j . We note that equation (8) is equivalent to computing a weighted average of z-scores.
Our use of FE-Meta-Tissue has two limitations. First, expression levels in two tissues in the same individual are not independent (sample overlap). Second, true effect sizes in two tissues may be different (heterogeneity). We discuss each limitation separately.
Regarding the sample overlap limitation, we determined that noise is mostly uncorrelated across tissues. For example, the correlation of normalized gene expression (read count) between whole blood and brain hippocampus is 0.11. Furthermore, the genetic correlation between these two tissues is around 0.67 36 and the heritability explained by cis-eQTLs is about 0.12. This indicates that the bulk of gene expression correlation is because of genetic correlations. Thus, the noise (environmental and measurement) in expression levels in two tissues in the same individual is close to independent.
Regarding the heterogeneity limitation, we determined that recently developed random-effect cross-tissue eQTL meta-analysis methods 48, 49, 56, 57 are not applicable to our problem. The meta-tissue method 40 is computationally intractable for datasets as large as GTEx (number of tissues and sample size). Other existing methods 49, 56, 57 , which are Bayesian methods, do not produce summary statistics (for example, z-scores) that are required to compute the MaxCPP annotation. Thus, these methods are not applicable to our work. Previous studies 12, 36 have shown that eQTL effects are highly correlated across tissues, suggesting that our fixed-effect meta-analysis approach is likely to be fairly close to optimal.
We note that the above limitations pertain only to power and not to false positives in our setting, which involves building eQTL annotations to apply to independent disease data. Our results ( Fig. 2 and Supplementary Tables 7, 27) show that we have improved our results by utilizing FE-Meta-Tissue. Furthermore, utilizing FE-Meta-Tissue increases replication rates for both eQTLs and hQTLs ( Supplementary Table 29 ).
Blood-and brain-related diseases and complex traits. We analyzed six autoimmune diseases: Crohn's disease 58 , rheumatoid arthritis (ref. 59 and UK Biobank), ulcerative colitis 58 , lupus 60 , celiac 61 and all autoimmune and inflammatory diseases in the UK Biobank).
We analyzed five blood cell traits: white blood cell count, red blood cell count, platelet count, eosinophil count and red blood cell distribution width. All of these datasets were obtained from the UK Biobank. Corresponding author(s):
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Experimental design 1. Sample size
Describe how sample size was determined. Our work is based on summary statistics. We analyzed existing data sets, Thus, no statistical method is used to compute the sample size.
Data exclusions
Describe any data exclusions.
Our study was restricted to data sets of European ancestry. No data was excluded from European individuals.
Replication
Describe whether the experimental findings were reliably reproduced.
We analyzed existing data sets. No replication was performed for experimental findings. We use GTEx and BLUEPRINT to replicate our findings.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
We analyzed existing data sets, Thus, no randomization was performed.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
We analyzed existing data sets, Thus, blinding was relevant to our work.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
